Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viridian Therapeutics Inc
(NQ:
VRDN
)
15.35
-0.23 (-1.48%)
Streaming Delayed Price
Updated: 11:07 AM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Viridian Therapeutics Inc
< Previous
1
2
3
4
Next >
Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket
November 30, 2022
Gainers Kalera Public Limited Company (NASDAQ: KAL) shares rose 33.3% to $0.2399 in pre-market trading after jumping 45% on Tuesday. Kalera recently announced restructuring process for German...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 30, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 29, 2022
Via
Benzinga
Viridian's Thyroid Eye Disease Candidate Shows Encouraging Early Data, Shares Surge
August 15, 2022
Via
Benzinga
Recap: Viridian Therapeutics Q2 Earnings
August 15, 2022
Viridian Therapeutics (NASDAQ:VRDN) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Viridian Therapeutics: Q1 Earnings Insights
May 12, 2022
Viridian Therapeutics (NASDAQ:VRDN) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
At Higher Dose, Viridian's Thyroid Eye Disease Candidate Shows Significant, Rapid Improvement In Signs & Symptoms
November 14, 2022
Via
Benzinga
Viridian Therapeutics Earnings Perspective: Return On Capital Employed
September 09, 2022
Benzinga Pro data, Viridian Therapeutics (NASDAQ:VRDN) reported Q2 sales of $256 thousand. Earnings fell to a loss of $29.49 million, resulting in a 14.78% decrease from last quarter.
Via
Benzinga
Why Viridian's CEO Isn't Sweating His Company's Second-Place Position
August 31, 2022
The company didn't plan to be first in thyroid eye disease. But it hopes to be best.
Via
Investor's Business Daily
$10 Million Bet On This Casino Stock? 4 Stocks Insiders Are Buying
August 22, 2022
Although US stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
Via
Benzinga
Earnings Scheduled For November 14, 2022
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Via
Benzinga
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
August 16, 2022
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.
Via
Benzinga
Viridian Therapeutics (VRDN) Stock Jumps 60% on Promising Clinical Trial
August 15, 2022
Viridian Therapeutics is among the biggest winners on Monday as it released encouraging clinical data, thus skyrocketing VRDN stock.
Via
InvestorPlace
Gold Drops Over 1%; Viridian Therapeutics Shares Spike Higher
August 15, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones around 170 points on Monday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 15, 2022
Via
Benzinga
Snap, Gilead Sciences And Some Other Big Stocks Moving Higher On Monday
August 15, 2022
Magic Empire Global Limited (NASDAQ: MEGL) shares climbed 80.9% to $14.87 on volatility following the company's IPO earlier this month.
Via
Benzinga
Dow Surges Over 100 Points; Crude Oil Falls Sharply
August 15, 2022
U.S. stocks traded turned higher midway through trading, with the Dow Jones gaining more than 100 points on Monday.
Via
Benzinga
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
August 15, 2022
Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New...
Via
Benzinga
New Contender Viridian Takes Aim At Horizon's Eye Drug, And Rockets
August 15, 2022
Horizon has the only approved thyroid eye disease treatment in the U.S., for now.
Via
Investor's Business Daily
U.S. Stocks Edge Lower; NY Empire State Manufacturing Index Drops In August
August 15, 2022
U.S. stocks traded slightly lower this morning, with the Dow Jones dropping around 40 points on Monday.
Via
Benzinga
Why Viridian Therapeutics Stock Is Soaring Today
August 15, 2022
Viridian Therapeutics Inc (NASDAQ: VRDN) shares are trading higher Monday after the company reported better-than-expected top-line results and announced initial clinical data from its ongoing trial of...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 13, 2022
Via
Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022
June 23, 2022
Upgrades
Via
Benzinga
110 Biggest Movers From Friday
May 16, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
Via
Benzinga
56 Stocks Moving In Friday's Mid-Day Session
May 13, 2022
Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to...
Via
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For May 12, 2022
May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.